Clinical Trials Logo

Clinical Trial Summary

This study will be conducted to compare the efficacy and safety of Parecoxib versus Paracetamol for treatment of acute renal colic due to ureteric stones.


Clinical Trial Description

Eligible patients will be randomized to one of the two treatment groups. Group 1 patients will receive IV 1 g of Paracetamol while group 2 patients will receive 40 mg of Parecoxib IV.

The Visual Analogue Scale (VAS) will be calculated on presentation and at 30 minutes after analgesia administration. Patients who do not respond to an initial dose of the analgesia will receive rescue analgesia in the form of Morphine, 01.mg/kg, IV. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03704623
Study type Interventional
Source Mansoura University
Contact
Status Completed
Phase Phase 4
Start date May 1, 2019
Completion date August 15, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03274700 - The Use of Tamsulosin in Treatment of (10-15 mm) Lower Ureteric Stones in Adults With Non-emergent Symptoms Early Phase 1
Recruiting NCT04851171 - Semi-rigid Ureteroscopy Versus Flexible Ureteroscopy For the Treatment of Proximal Ureteric Stone N/A
Completed NCT05218057 - to Compare the Effectiveness of Thulium Fiber Laser and Holmium YAG Laser for Ureteroscopic Lithotripsy N/A
Completed NCT06465784 - Laser Lithotripsy for Ureteral Stones Phase 4
Completed NCT03795545 - Ultraslow SWL Versus Slow SWL for Ureteric Stones With High Attenuation Value N/A
Recruiting NCT04759417 - Comparison of CHOKAI vs STONE Score to Predict the Presence of Ureteric Stones in Patients With Renal Colic: A Multi-center Prospective Observational Study
Completed NCT03404986 - Ultrasound Guided Ureteroscopy and Ureteric Stones N/A